PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression-Reference-Cited by-同舟云学术

PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression

Published:2018-11-19 Issue:1 Volume:129 Page:122-136
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Dong Shuai^ORCID,Harrington Bonnie K.,Hu Eileen Y.,Greene Joseph T.^ORCID,Lehman Amy M.,Tran Minh,Wasmuth Ronni L.,Long Meixiao,Muthusamy Natarajan^ORCID,Brown Jennifer R.,Johnson Amy J.,Byrd John C.

Funder

National Cancer Institute

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/99386/files/pdf

Reference84 articles.

1. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia;Burger;Hematology Am Soc Hematol Educ Program,2011

2. Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia

3. Chronic lymphocytic leukaemia;Kipps;Nat Rev Dis Primers,2017

4. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation

5. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PI3K Inhibitors in Hematology: When One Door Closes…;Clinical Cancer Research;2024-07-05

2. Lessons learned from the Eµ-TCL1 mouse model of CLL;Seminars in Hematology;2024-06

3. PI3Kδ Mediates Fibrosis by Patient-Derived Vitreous;Laboratory Investigation;2024-04

4. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer;Molecular Cancer;2023-08-18

5. Targeting the metabolism of tumor-infiltrating regulatory T cells;Trends in Immunology;2023-08